JDRF’s Advocacy Works to Ensure the T1D Community is Supported: Overview
As a research foundation, the advocacy work of JDRF supports our research priorities at every stage of the pipeline, whether securing funds for discovery or clinical trials, improving the regulatory landscape by creating new expedited approval pathways or securing public and private reimbursement for the drugs and devices Canadians living with type 1 diabetes (T1D) rely on.
We give a voice to the T1D community through our letter writing campaigns, petitions, meeting programs and lobby days, while also sitting on external advisory groups, responding to public consultations and preparing official government submissions. Through our advocacy approach, we offer a credible and trusted voice that is heard by government at all levels.
Advocacy highlights from 2021:
Previous Page
Research Goals
Next Page
Access For All